SCOLR Pharma, Inc.·4

Jun 13, 11:07 AM ET

JOHNSON CARL J 4

4 · SCOLR Pharma, Inc. · Filed Jun 13, 2011

Insider Transaction Report

Form 4
Period: 2011-06-09
Transactions
  • Award

    Director Stock Option (right-to-buy)

    2011-06-09+250,000250,000 total
    Exercise: $0.08Exp: 2021-06-09Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]This option will vest in twelve (12) equal monthly installments following the date of grant, provided the reporting person is still serving as a director at such time.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION